Pain Therapeutics Financial Statements
Pain Therapeutics Financial Information
| Company Type | Public Single Location |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Pain Therapeutics Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 66.0 | 53.9 | 5.1 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | 10.2 | (0.6) | (32.7) |
| Total Net Income ($ mil.) | 20.3 | 6.2 | (30.7) |
| Diluted EPS (Net Income) | 0.44 | 0.14 | (0.70) |
Pain Therapeutics Quarterly Statements
| Quarter Ending Jun 08 | Quarter Ending Mar 08 | Quarter Ending Dec 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 10.6 | 14.6 | 14.1 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (2.6) | 0.3 | (1.6) |
| Total Net Income ($ mil.) | (1.0) | 2.6 | 1.1 |
| Diluted EPS (Net Income) | (0.02) | 0.06 | 0.02 |
Pain Therapeutics Stock Quote & Chart
10/07/08 15:00:17 EST •
NASDAQ •
8.79
•
 -0.5700
•
-6.0897 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Pain Therapeutics Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 7.10 | 3.75 | 1.56 |
| Price/Earnings Ratio | 67.50 | 16.34 | 15.82 |
| Price/Book Ratio | 4.68 | 2.92 | 1.52 |
| Price/Cash Flow Ratio | -- | 13.17 | 9.88 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Pain Therapeutics Financial Ratios
Pain Therapeutics Competitive Intelligence
| Abbott Labs | Purdue Pharma | Roxane Laboratories | |
|---|---|---|---|
| Annual Sales ($ mil.) | 25,914.2 | 1,400.0 | 600.0 |
| Employees | 68,000 | 2,200 | 900 |
| Market Cap ($ mil.) | 90,488.8 | -- | -- |
Competitive Landscape
